Loading…
Reported covered position: N/A
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
First Responder Anthrax Preparedness Act
Client: EMERGENT BIOSOLUTIONS INC (FORMERLY BIOPORT CORPORATION) · Firm: DALRYMPLE & ASSOCIATES, LLC
Increased appropriations for CDC strategic national stockpile; increased appropriations for BARDA CBRN MCM advanced development; inceased appropriations for Project BioShield SRF; HR1300/S.1915-making anthrax vaccine available to 1st responders from the SNS prior to shelf live expiration for voluntary vaccination programs & HR 3299 for FDA priority review vouchers for developers of FDA approved MCMs against WMD CBRN threats.Contracting with CDC, HHS ASPR, BARDA and NIH for FDA licensed anthrax vaccine, botulinum antitoxin, AIGIV, BIGIV, VIGIV, third generation anthrax vaccine advanced development, RSDL for CHEMPACK,
Strengthening Public Health Emergency Response Act of 2016
Client: EMERGENT BIOSOLUTIONS INC (FORMERLY BIOPORT CORPORATION) · Firm: DALRYMPLE & ASSOCIATES, LLC
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
EMERGENT BIOSOLUTIONS INC (FORMERLY BIOPORT CORPORATION) via DALRYMPLE & ASSOCIATES, LLC
2016 · first_quarter · 1T
Contracts and/or supply of the military for stockpiling and use of medical countermeasures including anthrax vaccine, IVIG, AIGIV, BIGIV, and chemical WMD decontamination and neutralization lotion (RSDL).
Increased appropriations for CDC strategic national stockpile; increased appropriations for BARDA CBRN MCM advanced development; inceased appropriations for Project BioShield SRF; HR1300/S.1915-making anthrax vaccine available to 1st responders from the SNS prior to shelf live expiration for voluntary vaccination programs & HR 3299 for FDA priority review vouchers for developers of FDA approved MCMs against WMD CBRN threats.Contracting with CDC, HHS ASPR, BARDA and NIH for FDA licensed anthrax vaccine, botulinum antitoxin, AIGIV, BIGIV, VIGIV, third generation anthrax vaccine advanced development, RSDL for CHEMPACK,
Source: Senate LDA
| BIOTECHNOLOGY INDUSTRY ORGANIZATION |
| 8 |
| 1999–2002 |
| BRIGHTON BIOTECH, INC. | 5 | 2011 |
| CRUCELL, NA | 4 | 2009 |
Increased appropriations for CDC strategic national stockpile; increased appropriations for BARDA CBRN MCM advanced development; inceased appropriations for Project BioShield SRF; HR1300/S.1915-making anthrax vaccine available to 1st responders from the SNS prior to shelf live expiration for voluntary vaccination programs & HR 3299 for FDA priority review vouchers for developers of FDA approved MCMs against WMD CBRN threats.Contracting with CDC, HHS ASPR, BARDA and NIH for FDA licensed anthrax vaccine, botulinum antitoxin, AIGIV, BIGIV, VIGIV, third generation anthrax vaccine advanced development, RSDL for CHEMPACK,
First Responder Anthrax Preparedness Act
Client: EMERGENT BIOSOLUTIONS INC (FORMERLY BIOPORT CORPORATION) · Firm: DALRYMPLE & ASSOCIATES, LLC
Increased appropriations for CDC strategic national stockpile; increased appropriations for BARDA CBRN MCM advanced development; inceased appropriations for Project BioShield SRF; HR1300/S.1915-making anthrax vaccine available to 1st responders from the SNS prior to shelf live expiration for voluntary vaccination programs & HR 3299 for FDA priority review vouchers for developers of FDA approved MCMs against WMD CBRN threats.Contracting with CDC, HHS ASPR, BARDA and NIH for FDA licensed anthrax vaccine, botulinum antitoxin, AIGIV, BIGIV, VIGIV, third generation anthrax vaccine advanced development, RSDL for CHEMPACK,
First Responder Anthrax Preparedness Act
Client: EMERGENT BIOSOLUTIONS INC (FORMERLY BIOPORT CORPORATION) · Firm: DALRYMPLE & ASSOCIATES, LLC
Increased appropriations for CDC strategic national stockpile; increased appropriations for BARDA CBRN MCM advanced development; inceased appropriations for Project BioShield SRF; HR1300/S.1915-making anthrax vaccine available to 1st responders from the SNS prior to shelf live expiration for voluntary vaccination programs & HR 3299 for FDA priority review vouchers for developers of FDA approved MCMs against WMD CBRN threats.Contracting with CDC, HHS ASPR, BARDA and NIH for FDA licensed anthrax vaccine, botulinum antitoxin, AIGIV, BIGIV, VIGIV, third generation anthrax vaccine advanced development, RSDL for CHEMPACK,
Strengthening Public Health Emergency Response Act of 2016
Client: EMERGENT BIOSOLUTIONS INC (FORMERLY BIOPORT CORPORATION) · Firm: DALRYMPLE & ASSOCIATES, LLC
Increased appropriations for CDC strategic national stockpile; increased appropriations for BARDA CBRN MCM advanced development; inceased appropriations for Project BioShield SRF; HR1300/S.1915-making anthrax vaccine available to 1st responders from the SNS prior to shelf live expiration for voluntary vaccination programs & HR 3299 for FDA priority review vouchers for developers of FDA approved MCMs against WMD CBRN threats.Contracting with CDC, HHS ASPR, BARDA and NIH for FDA licensed anthrax vaccine, botulinum antitoxin, AIGIV, BIGIV, VIGIV, third generation anthrax vaccine advanced development, RSDL for CHEMPACK,
First Responder Anthrax Preparedness Act
Client: EMERGENT BIOSOLUTIONS INC (FORMERLY BIOPORT CORPORATION) · Firm: DALRYMPLE & ASSOCIATES, LLC
Increased appropriations for CDC strategic national stockpile; increased appropriations for BARDA CBRN MCM advanced development; inceased appropriations for Project BioShield SRF; HR1300/S.1915-making anthrax vaccine available to 1st responders from the SNS prior to shelf live expiration for voluntary vaccination programs & HR 3299 for FDA priority review vouchers for developers of FDA approved MCMs against WMD CBRN threats.Contracting with CDC, HHS ASPR, BARDA and NIH for FDA licensed anthrax vaccine, botulinum antitoxin, AIGIV, BIGIV, VIGIV, third generation anthrax vaccine advanced development, RSDL for CHEMPACK,
A bill to amend the Internal Revenue Code of 1986 to add meningococcal vaccines to the list of taxable vaccines for purposes of the Vaccine Injury Compensation Trust Fund.
Client: SANOFI PASTEUR · Firm: DALRYMPLE & ASSOCIATES, LLC
Vaccine excise tax covering newly recommended vaccines under the Vaccine Injury Compensation Program; S. 1008, H.R. 5970
Bioterror and Pandemic Preparedness Protection Act
Client: SANOFI PASTEUR · Firm: DALRYMPLE & ASSOCIATES, LLC
Vaccine & immunization programs; product liability; influenza vaccine stockpiles & appropriations & safety: S.2554, S. 3678, H.R. 5533, H.R. 5647, S. 3708, S. 1880, H.R. 2863, H.R. 5587, H.R. 4245, S. 1821, S. 96, S. 3627, S. 843, H.r. 3970, S. 1826, S. 1437, S. 969, S. 3492, S. 1527, H.R. 3502
Vaccine & immunization programs; product liability; influenza vaccine stockpiles & appropriations & safety: S.2554, S. 3678, H.R. 5533, H.R. 5647, S. 3708, S. 1880, H.R. 2863, H.R. 5587, H.R. 4245, S. 1821, S. 96, S. 3627, S. 843, H.r. 3970, S. 1826, S. 1437, S. 969, S. 3492, S. 1527, H.R. 3502
Pandemic Preparedness and Response Act
Client: SANOFI PASTEUR · Firm: DALRYMPLE & ASSOCIATES, LLC
Vaccine & immunization programs; product liability; influenza vaccine stockpiles & appropriations & safety: S.2554, S. 3678, H.R. 5533, H.R. 5647, S. 3708, S. 1880, H.R. 2863, H.R. 5587, H.R. 4245, S. 1821, S. 96, S. 3627, S. 843, H.r. 3970, S. 1826, S. 1437, S. 969, S. 3492, S. 1527, H.R. 3502
Vaccine & immunization programs; product liability; influenza vaccine stockpiles & appropriations & safety: S.2554, S. 3678, H.R. 5533, H.R. 5647, S. 3708, S. 1880, H.R. 2863, H.R. 5587, H.R. 4245, S. 1821, S. 96, S. 3627, S. 843, H.r. 3970, S. 1826, S. 1437, S. 969, S. 3492, S. 1527, H.R. 3502
National Biodefense and Pandemic Preparedness Act of 2005
Client: EMERGENT BIOSOLUTIONS INC (FORMERLY BIOPORT CORPORATION) · Firm: DALRYMPLE & ASSOCIATES, LLC
BioShield, Biodefense vaccine biological R&D, procurement for Strategic National Stockpile, & product liability related oversight, authorizing, & appropriations legislation; DHHS & CDC procurement of anthrax vaccines; S. 2564, S. 3678, H.R. 5533, H.R. 5647, S. 3708, S. 1880, H.R 2863
National Biodefense and Pandemic Preparedness Act of 2005
Client: SANOFI PASTEUR · Firm: DALRYMPLE & ASSOCIATES, LLC
Vaccine & immunization programs; product liability; influenza vaccine stockpiles & appropriations & safety: S.2554, S. 3678, H.R. 5533, H.R. 5647, S. 3708, S. 1880, H.R. 2863, H.R. 5587, H.R. 4245, S. 1821, S. 96, S. 3627, S. 843, H.r. 3970, S. 1826, S. 1437, S. 969, S. 3492, S. 1527, H.R. 3502
National Biodefense and Pandemic Preparedness Act of 2005
Client: ACAMBIS INC U S · Firm: DALRYMPLE & ASSOCIATES, LLC
Biodefense Vaccine R&D and acquisition under Project BioShield and the DHHS/CDC Strategic National Stockpile and related authorization and appropriations legislation; S. 1880, S. 2564, S. 3678, H.R. 5533, H.R. 5647, S. 3708, H.R. 2863
Comprehensive Entitlement Reform Commission Act of 2005
Client: EMERGENT BIOSOLUTIONS INC (FORMERLY BIOPORT CORPORATION) · Firm: DALRYMPLE & ASSOCIATES, LLC
Project BioShield and bioterrorism preparedness authorization and appropriatons legislation and related oversight issues; S. 2564, S. 3678, H.R. 5533, H.R. 5647, S. 3708, S. 1889, H.R. 2863
Affordability in the Individual Market Act
Client: SANOFI PASTEUR · Firm: DALRYMPLE & ASSOCIATES, LLC
Vaccine & immunization programs; product liability; influenza vaccine stockpiles & appropriations & safety: S.2554, S. 3678, H.R. 5533, H.R. 5647, S. 3708, S. 1880, H.R. 2863, H.R. 5587, H.R. 4245, S. 1821, S. 96, S. 3627, S. 843, H.r. 3970, S. 1826, S. 1437, S. 969, S. 3492, S. 1527, H.R. 3502
Biodefense and Pandemic Vaccine and Drug Development Act of 2006
Client: EMERGENT BIOSOLUTIONS INC (FORMERLY BIOPORT CORPORATION) · Firm: DALRYMPLE & ASSOCIATES, LLC
Project BioShield and bioterrorism preparedness authorization and appropriatons legislation and related oversight issues; S. 2564, S. 3678, H.R. 5533, H.R. 5647, S. 3708, S. 1889, H.R. 2863
Biodefense and Pandemic Vaccine and Drug Development Act of 2006
Client: ACAMBIS INC U S · Firm: DALRYMPLE & ASSOCIATES, LLC
Biodefense Vaccine R&D and acquisition under Project BioShield and the DHHS/CDC Strategic National Stockpile and related authorization and appropriations legislation; S. 1880, S. 2564, S. 3678, H.R. 5533, H.R. 5647, S. 3708, H.R. 2863
Biodefense and Pandemic Vaccine and Drug Development Act of 2006
Client: EMERGENT BIOSOLUTIONS INC (FORMERLY BIOPORT CORPORATION) · Firm: DALRYMPLE & ASSOCIATES, LLC
Defense authorization and appropriations legislation, MILVAX Program, Biodefense and biological product acquisition and R&D issues; S. 3678, S. 2564, H.R. 5533, S. 3708, H.R 5647
Biodefense and Pandemic Vaccine and Drug Development Act of 2006
Client: EMERGENT BIOSOLUTIONS INC (FORMERLY BIOPORT CORPORATION) · Firm: DALRYMPLE & ASSOCIATES, LLC
BioShield, Biodefense vaccine biological R&D, procurement for Strategic National Stockpile, & product liability related oversight, authorizing, & appropriations legislation; DHHS & CDC procurement of anthrax vaccines; S. 2564, S. 3678, H.R. 5533, H.R. 5647, S. 3708, S. 1880, H.R 2863
Federal Workforce Performance Appraisal and Management Improvement Act of 2006
Client: SANOFI PASTEUR · Firm: DALRYMPLE & ASSOCIATES, LLC
Vaccine & immunization programs; product liability; influenza vaccine stockpiles & appropriations & safety: S.2554, S. 3678, H.R. 5533, H.R. 5647, S. 3708, S. 1880, H.R. 2863, H.R. 5587, H.R. 4245, S. 1821, S. 96, S. 3627, S. 843, H.r. 3970, S. 1826, S. 1437, S. 969, S. 3492, S. 1527, H.R. 3502
Mercury Market Minimization Act of 2006
Client: SANOFI PASTEUR · Firm: DALRYMPLE & ASSOCIATES, LLC
Vaccine & immunization programs; product liability; influenza vaccine stockpiles & appropriations & safety: S.2554, S. 3678, H.R. 5533, H.R. 5647, S. 3708, S. 1880, H.R. 2863, H.R. 5587, H.R. 4245, S. 1821, S. 96, S. 3627, S. 843, H.r. 3970, S. 1826, S. 1437, S. 969, S. 3492, S. 1527, H.R. 3502
Pandemic and All-Hazards Preparedness Act
Client: EMERGENT BIOSOLUTIONS INC (FORMERLY BIOPORT CORPORATION) · Firm: DALRYMPLE & ASSOCIATES, LLC
Defense authorization and appropriations legislation, MILVAX Program, Biodefense and biological product acquisition and R&D issues; S. 3678, S. 2564, H.R. 5533, S. 3708, H.R 5647
Pandemic and All-Hazards Preparedness Act
Client: EMERGENT BIOSOLUTIONS INC (FORMERLY BIOPORT CORPORATION) · Firm: DALRYMPLE & ASSOCIATES, LLC
BioShield, Biodefense vaccine biological R&D, procurement for Strategic National Stockpile, & product liability related oversight, authorizing, & appropriations legislation; DHHS & CDC procurement of anthrax vaccines; S. 2564, S. 3678, H.R. 5533, H.R. 5647, S. 3708, S. 1880, H.R 2863
Pandemic and All-Hazards Preparedness Act
Client: EMERGENT BIOSOLUTIONS INC (FORMERLY BIOPORT CORPORATION) · Firm: DALRYMPLE & ASSOCIATES, LLC
Project BioShield and bioterrorism preparedness authorization and appropriatons legislation and related oversight issues; S. 2564, S. 3678, H.R. 5533, H.R. 5647, S. 3708, S. 1889, H.R. 2863
Pandemic and All-Hazards Preparedness Act
Client: ACAMBIS INC U S · Firm: DALRYMPLE & ASSOCIATES, LLC
Biodefense Vaccine R&D and acquisition under Project BioShield and the DHHS/CDC Strategic National Stockpile and related authorization and appropriations legislation; S. 1880, S. 2564, S. 3678, H.R. 5533, H.R. 5647, S. 3708, H.R. 2863
Pandemic and All-Hazards Preparedness Act
Client: SANOFI PASTEUR · Firm: DALRYMPLE & ASSOCIATES, LLC
Vaccine & immunization programs; product liability; influenza vaccine stockpiles & appropriations & safety: S.2554, S. 3678, H.R. 5533, H.R. 5647, S. 3708, S. 1880, H.R. 2863, H.R. 5587, H.R. 4245, S. 1821, S. 96, S. 3627, S. 843, H.r. 3970, S. 1826, S. 1437, S. 969, S. 3492, S. 1527, H.R. 3502
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2007
Client: SANOFI PASTEUR · Firm: DALRYMPLE & ASSOCIATES, LLC
NIAID and HHS OPHEMCE vaccine research and acquistion programs and appropriations; pandemic influenza research and preparedenss; CDC vaccine research and related appropriations; vaccine safety; H.R 5647, S. 3708, H.R. 2863, H.R. 4939
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2007
Client: EMERGENT BIOSOLUTIONS INC (FORMERLY BIOPORT CORPORATION) · Firm: DALRYMPLE & ASSOCIATES, LLC
BioShield, Biodefense vaccine biological R&D, procurement for Strategic National Stockpile, & product liability related oversight, authorizing, & appropriations legislation; DHHS & CDC procurement of anthrax vaccines; S. 2564, S. 3678, H.R. 5533, H.R. 5647, S. 3708, S. 1880, H.R 2863
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2007
Client: EMERGENT BIOSOLUTIONS INC (FORMERLY BIOPORT CORPORATION) · Firm: DALRYMPLE & ASSOCIATES, LLC
Project BioShield and bioterrorism preparedness authorization and appropriatons legislation and related oversight issues; S. 2564, S. 3678, H.R. 5533, H.R. 5647, S. 3708, S. 1889, H.R. 2863
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2007
Client: ACAMBIS INC U S · Firm: DALRYMPLE & ASSOCIATES, LLC
Biodefense Vaccine R&D and acquisition under Project BioShield and the DHHS/CDC Strategic National Stockpile and related authorization and appropriations legislation; S. 1880, S. 2564, S. 3678, H.R. 5533, H.R. 5647, S. 3708, H.R. 2863
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2007
Client: EMERGENT BIOSOLUTIONS INC (FORMERLY BIOPORT CORPORATION) · Firm: DALRYMPLE & ASSOCIATES, LLC
Defense authorization and appropriations legislation, MILVAX Program, Biodefense and biological product acquisition and R&D issues; S. 3678, S. 2564, H.R. 5533, S. 3708, H.R 5647
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2007
Client: SANOFI PASTEUR · Firm: DALRYMPLE & ASSOCIATES, LLC
Vaccine & immunization programs; product liability; influenza vaccine stockpiles & appropriations & safety: S.2554, S. 3678, H.R. 5533, H.R. 5647, S. 3708, S. 1880, H.R. 2863, H.R. 5587, H.R. 4245, S. 1821, S. 96, S. 3627, S. 843, H.r. 3970, S. 1826, S. 1437, S. 969, S. 3492, S. 1527, H.R. 3502
Vaccine & immunization programs; product liability; influenza vaccine stockpiles & appropriations & safety: S.2554, S. 3678, H.R. 5533, H.R. 5647, S. 3708, S. 1880, H.R. 2863, H.R. 5587, H.R. 4245, S. 1821, S. 96, S. 3627, S. 843, H.r. 3970, S. 1826, S. 1437, S. 969, S. 3492, S. 1527, H.R. 3502
Vaccine & immunization programs; product liability; influenza vaccine stockpiles & appropriations & safety: S.2554, S. 3678, H.R. 5533, H.R. 5647, S. 3708, S. 1880, H.R. 2863, H.R. 5587, H.R. 4245, S. 1821, S. 96, S. 3627, S. 843, H.r. 3970, S. 1826, S. 1437, S. 969, S. 3492, S. 1527, H.R. 3502
Attacking Viral Influenza Across Nations Act of 2005
Client: SANOFI PASTEUR · Firm: DALRYMPLE & ASSOCIATES, LLC
Vaccine & immunization programs; product liability; influenza vaccine stockpiles & appropriations & safety: S.2554, S. 3678, H.R. 5533, H.R. 5647, S. 3708, S. 1880, H.R. 2863, H.R. 5587, H.R. 4245, S. 1821, S. 96, S. 3627, S. 843, H.r. 3970, S. 1826, S. 1437, S. 969, S. 3492, S. 1527, H.R. 3502
Department of Veterans Affairs Claims Backlog Reduction Act of 2002
Client: EMERGENT BIOSOLUTIONS INC (FORMERLY BIOPORT CORPORATION) · Firm: DALRYMPLE & ASSOCIATES, LLC
Project BioShield and bioterrorism preparedness authorization and appropriatons legislation and related oversight issues; S. 2564, S. 3678, H.R. 5533, H.R. 5647, S. 3708, S. 1889, H.R. 2863
Department of Veterans Affairs Claims Backlog Reduction Act of 2002
Client: ACAMBIS INC U S · Firm: DALRYMPLE & ASSOCIATES, LLC
Biodefense Vaccine R&D and acquisition under Project BioShield and the DHHS/CDC Strategic National Stockpile and related authorization and appropriations legislation; S. 1880, S. 2564, S. 3678, H.R. 5533, H.R. 5647, S. 3708, H.R. 2863
Department of Veterans Affairs Claims Backlog Reduction Act of 2002
Client: EMERGENT BIOSOLUTIONS INC (FORMERLY BIOPORT CORPORATION) · Firm: DALRYMPLE & ASSOCIATES, LLC
BioShield, Biodefense vaccine biological R&D, procurement for Strategic National Stockpile, & product liability related oversight, authorizing, & appropriations legislation; DHHS & CDC procurement of anthrax vaccines; S. 2564, S. 3678, H.R. 5533, H.R. 5647, S. 3708, S. 1880, H.R 2863
Department of Veterans Affairs Claims Backlog Reduction Act of 2002
Client: SANOFI PASTEUR · Firm: DALRYMPLE & ASSOCIATES, LLC
Vaccine & immunization programs; product liability; influenza vaccine stockpiles & appropriations & safety: S.2554, S. 3678, H.R. 5533, H.R. 5647, S. 3708, S. 1880, H.R. 2863, H.R. 5587, H.R. 4245, S. 1821, S. 96, S. 3627, S. 843, H.r. 3970, S. 1826, S. 1437, S. 969, S. 3492, S. 1527, H.R. 3502
Department of Veterans Affairs Claims Backlog Reduction Act of 2002
Client: EMERGENT BIOSOLUTIONS INC (FORMERLY BIOPORT CORPORATION) · Firm: DALRYMPLE & ASSOCIATES, LLC
Defense authorization and appropriations legislation, MILVAX Program, Biodefense and biological product acquisition and R&D issues; S. 3678, S. 2564, H.R. 5533, S. 3708, H.R 5647
To extend the program under which temporary extended unemployment compensation is provided, and for other purposes.
Client: SANOFI PASTEUR · Firm: DALRYMPLE & ASSOCIATES, LLC
Vaccine & immunization programs; product liability; influenza vaccine stockpiles & appropriations & safety: S.2554, S. 3678, H.R. 5533, H.R. 5647, S. 3708, S. 1880, H.R. 2863, H.R. 5587, H.R. 4245, S. 1821, S. 96, S. 3627, S. 843, H.r. 3970, S. 1826, S. 1437, S. 969, S. 3492, S. 1527, H.R. 3502
To authorize the duration of the base contract of the Navy-Marine Corps Intranet contract to be more than five years but not more than seven years.
Client: ACAMBIS INC U S · Firm: DALRYMPLE & ASSOCIATES, LLC
Biodefense Vaccine R&D and acquisition under Project BioShield and the DHHS/CDC Strategic National Stockpile and related authorization and appropriations legislation; S. 1880, S. 2564, S. 3678, H.R. 5533, H.R. 5647, S. 3708, H.R. 2863
To authorize the duration of the base contract of the Navy-Marine Corps Intranet contract to be more than five years but not more than seven years.
Client: EMERGENT BIOSOLUTIONS INC (FORMERLY BIOPORT CORPORATION) · Firm: DALRYMPLE & ASSOCIATES, LLC
BioShield, Biodefense vaccine biological R&D, procurement for Strategic National Stockpile, & product liability related oversight, authorizing, & appropriations legislation; DHHS & CDC procurement of anthrax vaccines; S. 2564, S. 3678, H.R. 5533, H.R. 5647, S. 3708, S. 1880, H.R 2863
To authorize the duration of the base contract of the Navy-Marine Corps Intranet contract to be more than five years but not more than seven years.
Client: SANOFI PASTEUR · Firm: DALRYMPLE & ASSOCIATES, LLC
NIAID and HHS OPHEMCE vaccine research and acquistion programs and appropriations; pandemic influenza research and preparedenss; CDC vaccine research and related appropriations; vaccine safety; H.R 5647, S. 3708, H.R. 2863, H.R. 4939
To authorize the duration of the base contract of the Navy-Marine Corps Intranet contract to be more than five years but not more than seven years.
Client: SANOFI PASTEUR · Firm: DALRYMPLE & ASSOCIATES, LLC
Vaccine & immunization programs; product liability; influenza vaccine stockpiles & appropriations & safety: S.2554, S. 3678, H.R. 5533, H.R. 5647, S. 3708, S. 1880, H.R. 2863, H.R. 5587, H.R. 4245, S. 1821, S. 96, S. 3627, S. 843, H.r. 3970, S. 1826, S. 1437, S. 969, S. 3492, S. 1527, H.R. 3502
To authorize the duration of the base contract of the Navy-Marine Corps Intranet contract to be more than five years but not more than seven years.
Client: EMERGENT BIOSOLUTIONS INC (FORMERLY BIOPORT CORPORATION) · Firm: DALRYMPLE & ASSOCIATES, LLC
Defense authorization and appropriations legislation, MILVAX Program, Biodefense and biological product acquisition and R&D issues; S. 3678, S. 2564, H.R. 5533, S. 3708, H.R 5647
To authorize the duration of the base contract of the Navy-Marine Corps Intranet contract to be more than five years but not more than seven years.
Client: EMERGENT BIOSOLUTIONS INC (FORMERLY BIOPORT CORPORATION) · Firm: DALRYMPLE & ASSOCIATES, LLC
Project BioShield and bioterrorism preparedness authorization and appropriatons legislation and related oversight issues; S. 2564, S. 3678, H.R. 5533, H.R. 5647, S. 3708, S. 1889, H.R. 2863
Filing targets: Air Force, Dept of, Army, Dept of (Other), Centers For Disease Control & Prevention (CDC), Defense Logistics Agency, Defense Threat Reduction Agency (DTRA), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Joint Chiefs of Staff, Natl Institutes of Health (NIH), SENATE, White House Office
SANOFI PASTEUR via DALRYMPLE & ASSOCIATES, LLC
2016 · first_quarter · 1T
Coverage and Reimbursement for Administration of Vaccines and Immunization
CDC Strategic National Stockpile Appropriations for Smallpox Vaccine Procurement
Vaccine and immunization coverage. regulation, reimbursement, R&D and related issues
Filing targets: Advisory Council on Historic Preservation (ACHP), Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Homeland Security, Dept of (DHS), Natl Institutes of Health (NIH), Patent & Trademark Office (PTO), SENATE, White House Office
SANOFI PASTEUR via DALRYMPLE & ASSOCIATES, LLC
2015 · fourth_quarter · 4A
Vaccine and immunization coverage. regulation, reimbursement, R&D and related issues
Coverage and Reimbursement for Administration of Vaccines and Immunization
CDC Strategic National Stockpile Appropriations for Smallpox Vaccine Procurement
Filing targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Homeland Security, Dept of (DHS), Natl Institutes of Health (NIH), Patent & Trademark Office (PTO), SENATE, White House Office
EMERGENT BIOSOLUTIONS INC (FORMERLY BIOPORT CORPORATION) via DALRYMPLE & ASSOCIATES, LLC
2015 · third_quarter · Q3
Providing vaccines, therapeutics and neutralizing lotion for pre-event and post-event prophylaxis protection of warfighters from chemical and biological exposures from terrorist and naturally occurring exposures to anthrax, botulinum toxins, smallpox viruses and WMD chemical and organophosphates.
Biodefense vaccines and therapeutic R&D and procurement Appropriations and Government Grant and Contract Funding
Advocating the availability of FDA approved medical countermeasures for the protection of emergency responders against CBRN threats on a voluntary basis under appropriate medical supervision
Filing targets: Centers For Disease Control & Prevention (CDC), Defense Advanced Research Projects Agency (DARPA), Defense Logistics Agency, Defense Threat Reduction Agency (DTRA), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Joint Chiefs of Staff, Natl Institutes of Health (NIH), SENATE, White House Office
SANOFI PASTEUR via DALRYMPLE & ASSOCIATES, LLC
2015 · third_quarter · Q3
Coverage and Reimbursement for Administration of Vaccines and Immunization
Vaccine and immunization coverage. regulation, reimbursement, R&D and related issues
CDC Strategic National Stockpile Appropriations for Smallpox Vaccine Procurement
Filing targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Homeland Security, Dept of (DHS), Natl Institutes of Health (NIH), Patent & Trademark Office (PTO), SENATE, White House Office
EMERGENT BIOSOLUTIONS INC (FORMERLY BIOPORT CORPORATION) via DALRYMPLE & ASSOCIATES, LLC
2015 · fourth_quarter · Q4
Increased appropriations for CDC strategic national stockpile; increased appropriations for BARDA CBRN MCM advanced development; inceased appropriations for Project BioShield SRF; HR1300/S.1915-making anthrax vaccine available to 1st responders from the SNS prior to shelf live expiration for voluntary vaccination programs & HR 3299 for FDA priority review vouchers for developers of FDA approved MCMs against WMD CBRN threats.Contracting with CDC, HHS ASPR, BARDA and NIH for FDA licensed anthrax vaccine, botulinum antitoxin, AIGIV, BIGIV, VIGIV, third generation anthrax vaccine advanced development, RSDL for CHEMPACK,
Contracts and/or supply of the military for stockpiling and use of medical countermeasures including anthrax vaccine, IVIG, AIGIV, BIGIV, and chemical WMD decontamination and neutralization lotion (RSDL).
Filing targets: Air Force, Dept of, Army, Dept of (Other), Centers For Disease Control & Prevention (CDC), Defense Logistics Agency, Defense Threat Reduction Agency (DTRA), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Joint Chiefs of Staff, Natl Institutes of Health (NIH), SENATE, White House Office
SANOFI PASTEUR via DALRYMPLE & ASSOCIATES, LLC
2015 · fourth_quarter · Q4
Vaccine R&D, recommendations for use, safety and efficacy, reimbursement
Vaccine coverage and reimbursement
Filing targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE, White House Office
INTERCELL INC VALNEVA via DALRYMPLE & ASSOCIATES, LLC
2015 · second_quarter · 2T
Increase uptake among US military personnel of CDC and DoD Assistant Secretary of Health Affairs recommended Japanese Encephalitis vaccinations in disease endemic areas of SE Asia
Filing targets: Centers For Disease Control & Prevention (CDC), Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE
SANOFI PASTEUR via DALRYMPLE & ASSOCIATES, LLC
2015 · second_quarter · Q2
Coverage and Reimbursement for Administration of Vaccines and Immunization
Vaccine and immunization coverage. regulation, reimbursement, R&D and related issues
CDC Strategic National Stockpile Appropriations for Smallpox Vaccine Procurement
Filing targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Homeland Security, Dept of (DHS), Natl Institutes of Health (NIH), Patent & Trademark Office (PTO), SENATE, White House Office
EMERGENT BIOSOLUTIONS INC (FORMERLY BIOPORT CORPORATION) via DALRYMPLE & ASSOCIATES, LLC
2015 · second_quarter · Q2
Providing vaccines, therapeutics and neutralizing lotion for pre-event and post-event prophylaxis protection of warfighters from chemical and biological exposures from terrorist and naturally occurring exposures to anthrax, botulinum toxins, smallpox viruses and WMD chemical and organophosphates.
Advocating the availability of FDA approved medical countermeasures for the protection of emergency responders against CBRN threats on a voluntary basis under appropriate medical supervision
Biodefense vaccines and therapeutic R&D and procurement Appropriations and Government Grant and Contract Funding
EMERGENT BIOSOLUTIONS INC (FORMERLY BIOPORT CORPORATION) via DALRYMPLE & ASSOCIATES, LLC
2015 · first_quarter · 1A
Advocating the availability of FDA approved medical countermeasures for the protection of emergency responders against CBRN threats on a voluntary basis under appropriate medical supervision
Biodefense vaccines and therapeutic R&D and procurement Appropriations and Government Grant and Contract Funding
Providing vaccines, therapeutics and neutralizing lotion for pre-event and post-event prophylaxis protection of warfighters from chemical and biological exposures from terrorist and naturally occurring exposures to anthrax, botulinum toxins, smallpox viruses and WMD chemical and organophosphates.
INTERCELL INC VALNEVA via DALRYMPLE & ASSOCIATES, LLC
2015 · first_quarter · Q1
Increase uptake among US military personnel of CDC and DoD Assistant Secretary of Health Affairs recommended Japanese Encephalitis vaccinations in disease endemic areas of SE Asia
Filing targets: Centers For Disease Control & Prevention (CDC), Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE
SANOFI PASTEUR via DALRYMPLE & ASSOCIATES, LLC
2015 · first_quarter · Q1
Coverage and Reimbursement for Administration of Vaccines and Immunization
CDC Strategic National Stockpile Appropriations for Smallpox Vaccine Procurement
Vaccine and immunization coverage. regulation, reimbursement, R&D and related issues
Filing targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Homeland Security, Dept of (DHS), Natl Institutes of Health (NIH), Patent & Trademark Office (PTO), SENATE, White House Office
INTERCELL INC VALNEVA via DALRYMPLE & ASSOCIATES, LLC
2014 · fourth_quarter · Q4
Acquisition of Japanese Encephalitis Vaccine
DoD acquisiton and use of Japanese Encephalitis Vaccine
Filing targets: Defense Logistics Agency, Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE
SANOFI PASTEUR via DALRYMPLE & ASSOCIATES, LLC
2014 · fourth_quarter · Q4
Childhood, adult and biodefense vaccine issues
Funding and appropriations for adult, childhood and biodefense vaccines and other medical countermeasures
Filing targets: Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
EMERGENT BIOSOLUTIONS INC (FORMERLY BIOPORT CORPORATION) via DALRYMPLE & ASSOCIATES, LLC
2014 · fourth_quarter · Q4
Anthrax vaccine, antitoxin and immunoglobulin, and CBRN medical countermeasure research, acquisition, legislation, funding, appropriations and oversight.
Anthrax vaccine, anthrax antitoxin, anthrax immune globulin and CBRN Medical Countermeasures research, acquisition and funding, legislation, appropriations, and oversight and medical countermeasure first responder preparedness.
Biodefense and naturally-occurring vaccine and related biological therapeutic products and civilian oncology therapeutic products research and development funding, legislation, appropriations and oversight.
SANOFI PASTEUR via DALRYMPLE & ASSOCIATES, LLC
2014 · third_quarter · Q3
Childhood, adult and biodefense vaccine issues
Funding and appropriations for adult, childhood and biodefense vaccines and other medical countermeasures
Filing targets: Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
SANOFI PASTEUR via DALRYMPLE & ASSOCIATES, LLC
2014 · second_quarter · Q2
Childhood, adult and biodefense vaccine issues
Funding and appropriations for adult, childhood and biodefense vaccines and other medical countermeasures
Filing targets: Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
INTERCELL INC VALNEVA via DALRYMPLE & ASSOCIATES, LLC
2014 · third_quarter · Q3
DoD acquisiton and use of Japanese Encephalitis Vaccine
Acquisition of Japanese Encephalitis Vaccine
Filing targets: Defense Logistics Agency, Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE
EMERGENT BIOSOLUTIONS INC (FORMERLY BIOPORT CORPORATION) via DALRYMPLE & ASSOCIATES, LLC
2014 · third_quarter · Q3
Anthrax vaccine, anthrax antitoxin, anthrax immune globulin and CBRN Medical Countermeasures research, acquisition and funding, legislation, appropriations, and oversight and medical countermeasure first responder preparedness.
Biodefense and naturally-occurring vaccine and related biological therapeutic products and civilian oncology therapeutic products research and development funding, legislation, appropriations and oversight.
Anthrax vaccine, antitoxin and immunoglobulin, and CBRN medical countermeasure research, acquisition, legislation, funding, appropriations and oversight.
SANOFI PASTEUR via DALRYMPLE & ASSOCIATES, LLC
2014 · second_quarter · Q2
Funding and appropriations for adult, childhood and biodefense vaccines and other medical countermeasures
Childhood, adult and biodefense vaccine issues
Filing targets: Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
INTERCELL INC VALNEVA via DALRYMPLE & ASSOCIATES, LLC
2014 · second_quarter · Q2
Acquisition of Japanese Encephalitis Vaccine
DoD acquisiton and use of Japanese Encephalitis Vaccine
Filing targets: Defense Logistics Agency, Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE
EMERGENT BIOSOLUTIONS INC (FORMERLY BIOPORT CORPORATION) via DALRYMPLE & ASSOCIATES, LLC
2014 · second_quarter · Q2
Biodefense and naturally-occurring vaccine and related biological therapeutic products and civilian oncology therapeutic products research and development funding, legislation, appropriations and oversight.
Anthrax vaccine, antitoxin and immunoglobulin, and CBRN medical countermeasure research, acquisition, legislation, funding, appropriations and oversight.
Anthrax vaccine, anthrax antitoxin, anthrax immune globulin and CBRN Medical Countermeasures research, acquisition and funding, legislation, appropriations, and oversight and medical countermeasure first responder preparedness.
EMERGENT BIOSOLUTIONS INC (FORMERLY BIOPORT CORPORATION) via DALRYMPLE & ASSOCIATES, LLC
2014 · first_quarter · Q1
Biodefense and naturally-occurring vaccine and related biological therapeutic products and civilian oncology therapeutic products research and development funding, legislation, appropriations and oversight.
Anthrax vaccine, antitoxin and immunoglobulin, and CBRN medical countermeasure research, acquisition, legislation, funding, appropriations and oversight.
Anthrax vaccine, anthrax antitoxin, anthrax immune globulin and CBRN Medical Countermeasures research, acquisition and funding, legislation, appropriations, and oversight and medical countermeasure first responder preparedness.
SANOFI PASTEUR via DALRYMPLE & ASSOCIATES, LLC
2014 · first_quarter · Q1
Funding and appropriations for adult, childhood and biodefense vaccines and other medical countermeasures
Childhood, adult and biodefense vaccine issues
Filing targets: Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
INTERCELL INC VALNEVA via DALRYMPLE & ASSOCIATES, LLC
2014 · first_quarter · Q1
DoD acquisiton and use of Japanese Encephalitis Vaccine
Acquisition of Japanese Encephalitis Vaccine
Filing targets: Defense Logistics Agency, Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE
INTERCELL INC VALNEVA via DALRYMPLE & ASSOCIATES, LLC
2013 · fourth_quarter · Q4
DoD acquisiton and use of Japanese Encephalitis Vaccine
Acquisition of Japanese Encephalitis Vaccine
Filing targets: Defense Logistics Agency, Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE
SANOFI PASTEUR via DALRYMPLE & ASSOCIATES, LLC
2013 · fourth_quarter · Q4
Funding and appropriations for adult, childhood and biodefense vaccines and other medical countermeasures
Childhood, adult and biodefense vaccine issues
Filing targets: Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
EMERGENT BIOSOLUTIONS INC (FORMERLY BIOPORT CORPORATION) via DALRYMPLE & ASSOCIATES, LLC
2013 · fourth_quarter · 4A
Vaccination of first responders; Chempack
Acquisition and R&D for anthrax vaccine and other CBRN medical countermeasures
Funding and appropriations for acquisition and R&D related to anthrax vaccine and other CBRN medical countermeasures
EMERGENT BIOSOLUTIONS INC (FORMERLY BIOPORT CORPORATION) via DALRYMPLE & ASSOCIATES, LLC
2013 · third_quarter · Q3
Biodefence vaccines and medical countermeasures
Filing targets: Centers For Disease Control & Prevention (CDC), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Natl Institutes of Health (NIH), SENATE
SANOFI PASTEUR via DALRYMPLE & ASSOCIATES, LLC
2013 · second_quarter · Q2
Vaccine and immunization finance, reimbursement, acquisition, regulation, standards of quality and care, liability, public health and emergency preparedness funding, legislation, appropriations and oversight.
Vaccine research and development legislation, funding, appropriations and oversight.
Filing targets: Army, Dept of (Other), Centers For Disease Control & Prevention (CDC), Defense Threat Reduction Agency (DTRA), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE, State, Dept of (DOS), U.S. Agency for International Development (USAID), Veterans Affairs, Dept of (VA), White House Office
INTERCELL INC VALNEVA via DALRYMPLE & ASSOCIATES, LLC
2013 · second_quarter · Q2
Japanese Encephalitis Vaccination Advocacy and Funding
Filing targets: Air Force, Dept of, Army, Dept of (Other), Centers For Disease Control & Prevention (CDC), Defense Logistics Agency, Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Natl Guard, Navy, Dept of, Office of the Secretary of Defense, Pentagon Force Protection Agency, SENATE, State, Dept of (DOS), Veterans Affairs, Dept of (VA)
EMERGENT BIOSOLUTIONS INC (FORMERLY BIOPORT CORPORATION) via DALRYMPLE & ASSOCIATES, LLC
2013 · second_quarter · Q2
Biodefense and naturally-occurring vaccine and related biological therapeutic products and civilian oncology therapeutic products research and development funding, legislation, appropriations and oversight.
Anthrax vaccine and anthrax immune globulin research, acquisition and immunization funding, legislation, appropriations, and oversight.
Anthrax vaccine and immunoglobulin research, acquisition, immunization, legislation, funding, appropriations and oversight.
Filing targets: Army, Dept of (Other), Ballistic Missile Defense Organization, Centers For Disease Control & Prevention (CDC), Defense Threat Reduction Agency (DTRA), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Natl Institutes of Health (NIH), SENATE, White House Office
INTERCELL INC VALNEVA via DALRYMPLE & ASSOCIATES, LLC
2013 · first_quarter · Q1
Japanese Encephalitis Vaccination Advocacy and Funding
Filing targets: Air Force, Dept of, Army, Dept of (Other), Centers For Disease Control & Prevention (CDC), Defense Logistics Agency, Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Natl Guard, Navy, Dept of, Office of the Secretary of Defense, Pentagon Force Protection Agency, SENATE, State, Dept of (DOS), Veterans Affairs, Dept of (VA)
DISCOVERY LABORATORIES via DALRYMPLE & ASSOCIATES, LLC
2013 · first_quarter · Q1
Small peptide synthetic lung surfactant and delivery device medical countermeasures research and development agency grant and contract funding opportunities, legislation, appropriations, and oversight.
Small peptide synthetic lung surfactant and delivery devices CBRN threat medical countermeasures research and development defense agency grant and contract funding opportunities, legislation, appropriations and oversight.
Small peptide synthetic lung surfactant and medical device delivery medical countermeasures against CBRN threats research and development grant and contract funding opportunities, legislation, appropriations and oversight.
SANOFI PASTEUR via DALRYMPLE & ASSOCIATES, LLC
2013 · first_quarter · Q1
Vaccine and immunization finance, reimbursement, acquisition, regulation, standards of quality and care, liability, public health and emergency preparedness funding, legislation, appropriations and oversight.
Vaccine research and development legislation, funding, appropriations and oversight.
Filing targets: Army, Dept of (Other), Centers For Disease Control & Prevention (CDC), Defense Threat Reduction Agency (DTRA), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE, State, Dept of (DOS), U.S. Agency for International Development (USAID), Veterans Affairs, Dept of (VA), White House Office
EMERGENT BIOSOLUTIONS INC (FORMERLY BIOPORT CORPORATION) via DALRYMPLE & ASSOCIATES, LLC
2013 · first_quarter · Q1
Anthrax vaccine and anthrax immune globulin research, acquisition and immunization funding, legislation, appropriations, and oversight.
Anthrax vaccine and immunoglobulin research, acquisition, immunization, legislation, funding, appropriations and oversight.
Biodefense and naturally-occurring vaccine and related biological therapeutic products and civilian oncology therapeutic products research and development funding, legislation, appropriations and oversight.
Filing targets: Army, Dept of (Other), Ballistic Missile Defense Organization, Centers For Disease Control & Prevention (CDC), Defense Threat Reduction Agency (DTRA), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Natl Institutes of Health (NIH), SENATE, White House Office
INTERCELL INC VALNEVA via DALRYMPLE & ASSOCIATES, LLC
2013 · first_quarter · RR
Japanese Encephalitis Vaccination Advocacy and Funding
EMERGENT BIOSOLUTIONS INC (FORMERLY BIOPORT CORPORATION) via DALRYMPLE & ASSOCIATES, LLC
2012 · fourth_quarter · Q4
Anthrax vaccine and anthrax immune globulin research, acquisition and immunization funding, legislation, appropriations, and oversight.
Anthrax vaccine and immunoglobulin research, acquisition, immunization, legislation, funding, appropriations and oversight.
Biodefense and naturally-occurring vaccine and related biological therapeutic products and civilian oncology therapeutic products research and development funding, legislation, appropriations and oversight.
Filing targets: Army, Dept of (Other), Ballistic Missile Defense Organization, Centers For Disease Control & Prevention (CDC), Defense Threat Reduction Agency (DTRA), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Natl Institutes of Health (NIH), SENATE, White House Office
SANOFI PASTEUR via DALRYMPLE & ASSOCIATES, LLC
2012 · fourth_quarter · Q4
Vaccine research and development legislation, funding, appropriations and oversight.
Vaccine and immunization finance, reimbursement, acquisition, regulation, standards of quality and care, liability, public health and emergency preparedness funding, legislation, appropriations and oversight.
Filing targets: Army, Dept of (Other), Centers For Disease Control & Prevention (CDC), Defense Threat Reduction Agency (DTRA), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE, State, Dept of (DOS), U.S. Agency for International Development (USAID), Veterans Affairs, Dept of (VA), White House Office
DISCOVERY LABORATORIES via DALRYMPLE & ASSOCIATES, LLC
2012 · fourth_quarter · 4T
Small peptide synthetic lung surfactant and delivery device medical countermeasures research and development agency grant and contract funding opportunities, legislation, appropriations, and oversight.
Small peptide synthetic lung surfactant and delivery devices CBRN threat medical countermeasures research and development defense agency grant and contract funding opportunities, legislation, appropriations and oversight.
Small peptide synthetic lung surfactant and medical device delivery medical countermeasures against CBRN threats research and development grant and contract funding opportunities, legislation, appropriations and oversight.
DISCOVERY LABORATORIES via DALRYMPLE & ASSOCIATES, LLC
2012 · third_quarter · Q3
Small peptide synthetic lung surfactant and delivery devices CBRN threat medical countermeasures research and development defense agency grant and contract funding opportunities, legislation, appropriations and oversight.
Small peptide synthetic lung surfactant and delivery device medical countermeasures research and development agency grant and contract funding opportunities, legislation, appropriations, and oversight.
Small peptide synthetic lung surfactant and medical device delivery medical countermeasures against CBRN threats research and development grant and contract funding opportunities, legislation, appropriations and oversight.
SANOFI PASTEUR via DALRYMPLE & ASSOCIATES, LLC
2012 · third_quarter · Q3
Vaccine research and development legislation, funding, appropriations and oversight.
Vaccine and immunization finance, reimbursement, acquisition, regulation, standards of quality and care, liability, public health and emergency preparedness funding, legislation, appropriations and oversight.
Filing targets: Army, Dept of (Other), Centers For Disease Control & Prevention (CDC), Defense Threat Reduction Agency (DTRA), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE, State, Dept of (DOS), U.S. Agency for International Development (USAID), Veterans Affairs, Dept of (VA), White House Office
EMERGENT BIOSOLUTIONS INC (FORMERLY BIOPORT CORPORATION) via DALRYMPLE & ASSOCIATES, LLC
2012 · third_quarter · Q3
Biodefense and naturally-occurring vaccine and related biological therapeutic products and civilian oncology therapeutic products research and development funding, legislation, appropriations and oversight.
Anthrax vaccine and immunoglobulin research, acquisition, immunization, legislation, funding, appropriations and oversight.
Anthrax vaccine and anthrax immune globulin research, acquisition and immunization funding, legislation, appropriations, and oversight.
Filing targets: Army, Dept of (Other), Ballistic Missile Defense Organization, Centers For Disease Control & Prevention (CDC), Defense Threat Reduction Agency (DTRA), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Natl Institutes of Health (NIH), SENATE, White House Office
DISCOVERY LABORATORIES via DALRYMPLE & ASSOCIATES, LLC
2012 · second_quarter · Q2
Small peptide synthetic lung surfactant and delivery devices CBRN threat medical countermeasures research and development defense agency grant and contract funding opportunities, legislation, appropriations and oversight.
Small peptide synthetic lung surfactant and delivery device medical countermeasures research and development agency grant and contract funding opportunities, legislation, appropriations, and oversight.
Small peptide synthetic lung surfactant and medical device delivery medical countermeasures against CBRN threats research and development grant and contract funding opportunities, legislation, appropriations and oversight.
EMERGENT BIOSOLUTIONS INC (FORMERLY BIOPORT CORPORATION) via DALRYMPLE & ASSOCIATES, LLC
2012 · second_quarter · Q2
Anthrax vaccine and anthrax immune globulin research, acquisition and immunization funding, legislation, appropriations, and oversight.
Biodefense and naturally-occurring vaccine and related biological therapeutic products and civilian oncology therapeutic products research and development funding, legislation, appropriations and oversight.
Anthrax vaccine and immunoglobulin research, acquisition, immunization, legislation, funding, appropriations and oversight.
Filing targets: Army, Dept of (Other), Ballistic Missile Defense Organization, Centers For Disease Control & Prevention (CDC), Defense Threat Reduction Agency (DTRA), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Natl Institutes of Health (NIH), SENATE, White House Office
SANOFI PASTEUR via DALRYMPLE & ASSOCIATES, LLC
2012 · second_quarter · Q2
Vaccine research and development legislation, funding, appropriations and oversight.
Vaccine and immunization finance, reimbursement, acquisition, regulation, standards of quality and care, liability, public health and emergency preparedness funding, legislation, appropriations and oversight.
Filing targets: Army, Dept of (Other), Centers For Disease Control & Prevention (CDC), Defense Threat Reduction Agency (DTRA), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE, State, Dept of (DOS), U.S. Agency for International Development (USAID), Veterans Affairs, Dept of (VA), White House Office
SANOFI PASTEUR via DALRYMPLE & ASSOCIATES, LLC
2012 · first_quarter · Q1
Vaccine research and development legislation, funding, appropriations and oversight.
Vaccine and immunization finance, reimbursement, acquisition, regulation, standards of quality and care, liability, public health and emergency preparedness funding, legislation, appropriations and oversight.
Filing targets: Army, Dept of (Other), Centers For Disease Control & Prevention (CDC), Defense Threat Reduction Agency (DTRA), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE, State, Dept of (DOS), U.S. Agency for International Development (USAID), Veterans Affairs, Dept of (VA), White House Office
EMERGENT BIOSOLUTIONS INC (FORMERLY BIOPORT CORPORATION) via DALRYMPLE & ASSOCIATES, LLC
2012 · first_quarter · Q1
Anthrax vaccine and anthrax immune globulin research, acquisition and immunization funding, legislation, appropriations, and oversight.
Anthrax vaccine and immunoglobulin research, acquisition, immunization, legislation, funding, appropriations and oversight.
Biodefense and naturally-occurring vaccine and related biological therapeutic products and civilian oncology therapeutic products research and development funding, legislation, appropriations and oversight.
Filing targets: Army, Dept of (Other), Ballistic Missile Defense Organization, Centers For Disease Control & Prevention (CDC), Defense Threat Reduction Agency (DTRA), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Natl Institutes of Health (NIH), SENATE, White House Office
DISCOVERY LABORATORIES via DALRYMPLE & ASSOCIATES, LLC
2012 · first_quarter · Q1
Small peptide synthetic lung surfactant and medical device delivery medical countermeasures against CBRN threats research and development grant and contract funding opportunities, legislation, appropriations and oversight.
Small peptide synthetic lung surfactant and delivery devices CBRN threat medical countermeasures research and development defense agency grant and contract funding opportunities, legislation, appropriations and oversight.
Small peptide synthetic lung surfactant and delivery device medical countermeasures research and development agency grant and contract funding opportunities, legislation, appropriations, and oversight.
DISCOVERY LABORATORIES via DALRYMPLE & ASSOCIATES, LLC
2011 · fourth_quarter · Q4
Small peptide synthetic lung surfactant and medical device delivery medical countermeasures against CBRN threats research and development grant and contract funding opportunities, legislation, appropriations and oversight.
Small peptide synthetic lung surfactant and delivery device medical countermeasures research and development agency grant and contract funding opportunities, legislation, appropriations, and oversight.
Small peptide synthetic lung surfactant and delivery devices CBRN threat medical countermeasures research and development defense agency grant and contract funding opportunities, legislation, appropriations and oversight.
BRIGHTON BIOTECH, INC. via DALRYMPLE & ASSOCIATES, LLC
2011 · fourth_quarter · 4T
Biodefense small molecule medical countermeasure against CBRN threats and orphan drug research and development funding, legislation, appropriations and oversight.
Small molecule medical countermeasure research and development agency funding, legislation, appropriations, and oversight.
Small molecule CBRN threat medical countermeasure research and development defense agency funding legislation, appropriations and oversight.
Filing targets: Army, Dept of (Other), Ballistic Missile Defense Organization, Centers For Disease Control & Prevention (CDC), Defense Threat Reduction Agency (DTRA), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Natl Institutes of Health (NIH), SENATE, White House Office
SANOFI PASTEUR via DALRYMPLE & ASSOCIATES, LLC
2011 · fourth_quarter · Q4
Vaccine and immunization finance, reimbursement, acquisition, regulation, standards of quality and care, liability, public health and emergency preparedness funding, legislation, appropriations and oversight.
Vaccine research and development legislation, funding, appropriations and oversight.
Filing targets: Army, Dept of (Other), Centers For Disease Control & Prevention (CDC), Defense Threat Reduction Agency (DTRA), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE, State, Dept of (DOS), U.S. Agency for International Development (USAID), Veterans Affairs, Dept of (VA), White House Office
EMERGENT BIOSOLUTIONS INC (FORMERLY BIOPORT CORPORATION) via DALRYMPLE & ASSOCIATES, LLC
2011 · fourth_quarter · Q4
Biodefense and naturally-occurring vaccine and related biological therapeutic products and civilian oncology therapeutic products research and development funding, legislation, appropriations and oversight.
Anthrax vaccine and immunoglobulin research, acquisition, immunization, legislation, funding, appropriations and oversight.
Anthrax vaccine and anthrax immune globulin research, acquisition and immunization funding, legislation, appropriations, and oversight.
Filing targets: Army, Dept of (Other), Ballistic Missile Defense Organization, Centers For Disease Control & Prevention (CDC), Defense Threat Reduction Agency (DTRA), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Natl Institutes of Health (NIH), SENATE, White House Office
SANOFI PASTEUR via DALRYMPLE & ASSOCIATES, LLC
2011 · third_quarter · Q3
Vaccine research and development legislation, funding, appropriations and oversight.
Vaccine and immunization finance, reimbursement, acquisition, regulation, standards of quality and care, liability, public health and emergency preparedness funding, legislation, appropriations and oversight.
Filing targets: Army, Dept of (Other), Centers For Disease Control & Prevention (CDC), Defense Threat Reduction Agency (DTRA), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE, State, Dept of (DOS), U.S. Agency for International Development (USAID), Veterans Affairs, Dept of (VA), White House Office
EMERGENT BIOSOLUTIONS INC (FORMERLY BIOPORT CORPORATION) via DALRYMPLE & ASSOCIATES, LLC
2011 · third_quarter · Q3
Anthrax vaccine and immunoglobulin research, acquisition, immunization, legislation, funding, appropriations and oversight.
Biodefense and naturally-occurring vaccine and related biological therapeutic products and civilian oncology therapeutic products research and development funding, legislation, appropriations and oversight.
Anthrax vaccine and anthrax immune globulin research, acquisition and immunization funding, legislation, appropriations, and oversight.
Filing targets: Army, Dept of (Other), Ballistic Missile Defense Organization, Centers For Disease Control & Prevention (CDC), Defense Threat Reduction Agency (DTRA), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Natl Institutes of Health (NIH), SENATE, White House Office
BRIGHTON BIOTECH, INC. via DALRYMPLE & ASSOCIATES, LLC
2011 · third_quarter · Q3
Biodefense small molecule medical countermeasure against CBRN threats and orphan drug research and development funding, legislation, appropriations and oversight.
Small molecule CBRN threat medical countermeasure research and development defense agency funding legislation, appropriations and oversight.
Small molecule medical countermeasure research and development agency funding, legislation, appropriations, and oversight.
Filing targets: Army, Dept of (Other), Ballistic Missile Defense Organization, Centers For Disease Control & Prevention (CDC), Defense Threat Reduction Agency (DTRA), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Natl Institutes of Health (NIH), SENATE, White House Office
DISCOVERY LABORATORIES via DALRYMPLE & ASSOCIATES, LLC
2011 · third_quarter · Q3
Small peptide synthetic lung surfactant and delivery device medical countermeasures research and development agency grant and contract funding opportunities, legislation, appropriations, and oversight.
Small peptide synthetic lung surfactant and medical device delivery medical countermeasures against CBRN threats research and development grant and contract funding opportunities, legislation, appropriations and oversight.
Small peptide synthetic lung surfactant and delivery devices CBRN threat medical countermeasures research and development defense agency grant and contract funding opportunities, legislation, appropriations and oversight.
BRIGHTON BIOTECH, INC. via DALRYMPLE & ASSOCIATES, LLC
2011 · second_quarter · Q2
Biodefense small molecule medical countermeasure against CBRN threats and orphan drug research and development funding, legislation, appropriations and oversight.
Small molecule medical countermeasure research and development agency funding, legislation, appropriations, and oversight.
Small molecule CBRN threat medical countermeasure research and development defense agency funding legislation, appropriations and oversight.
Filing targets: Army, Dept of (Other), Ballistic Missile Defense Organization, Centers For Disease Control & Prevention (CDC), Defense Threat Reduction Agency (DTRA), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Natl Institutes of Health (NIH), SENATE, White House Office
DISCOVERY LABORATORIES via DALRYMPLE & ASSOCIATES, LLC
2011 · second_quarter · Q2
Small peptide synthetic lung surfactant and medical device delivery medical countermeasures against CBRN threats research and development grant and contract funding opportunities, legislation, appropriations and oversight.
Small peptide synthetic lung surfactant and delivery devices CBRN threat medical countermeasures research and development defense agency grant and contract funding opportunities, legislation, appropriations and oversight.
Small peptide synthetic lung surfactant and delivery device medical countermeasures research and development agency grant and contract funding opportunities, legislation, appropriations, and oversight.
SANOFI PASTEUR via DALRYMPLE & ASSOCIATES, LLC
2011 · second_quarter · Q2
Vaccine research and development legislation, funding, appropriations and oversight.
Vaccine and immunization finance, reimbursement, acquisition, regulation, standards of quality and care, liability, public health and emergency preparedness funding, legislation, appropriations and oversight.
Filing targets: Army, Dept of (Other), Centers For Disease Control & Prevention (CDC), Defense Threat Reduction Agency (DTRA), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE, State, Dept of (DOS), U.S. Agency for International Development (USAID), Veterans Affairs, Dept of (VA), White House Office
EMERGENT BIOSOLUTIONS INC (FORMERLY BIOPORT CORPORATION) via DALRYMPLE & ASSOCIATES, LLC
2011 · second_quarter · Q2
Biodefense and naturally-occurring vaccine and related biological therapeutic products and civilian oncology therapeutic products research and development funding, legislation, appropriations and oversight.
Anthrax vaccine and immunoglobulin research, acquisition, immunization, legislation, funding, appropriations and oversight.
Anthrax vaccine and anthrax immune globulin research, acquisition and immunization funding, legislation, appropriations, and oversight.
Filing targets: Army, Dept of (Other), Ballistic Missile Defense Organization, Centers For Disease Control & Prevention (CDC), Defense Threat Reduction Agency (DTRA), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Natl Institutes of Health (NIH), SENATE, White House Office
DISCOVERY LABORATORIES via DALRYMPLE & ASSOCIATES, LLC
2011 · first_quarter · RR
Government agency Therapeutic product R&D funding opportunities
Government agency Therapeutic product R&D funding opportunities
Government agency Therapeutic product R&D funding opportunities
PULMATRIX, INC. via DALRYMPLE & ASSOCIATES, LLC
2011 · first_quarter · 1@
Appropriations and funding under federal government contracts for development of broad spectrum products and delivery systems for the prevention, prophylaxis, treatment and halting transmission of infectious respiratory diseases.
Filing targets: Army, Dept of (Other), Centers For Disease Control & Prevention (CDC), Defense Advanced Research Projects Agency (DARPA), Defense Threat Reduction Agency (DTRA), Defense, Dept of (DOD), Executive Office of the President (EOP), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Natl Institutes of Health (NIH), SENATE, State, Dept of (DOS)
BRIGHTON BIOTECH, INC. via DALRYMPLE & ASSOCIATES, LLC
2011 · first_quarter · Q1
Biodefense small molecule medical countermeasure against CBRN threats and orphan drug research and development funding, legislation, appropriations and oversight.
Small molecule CBRN threat medical countermeasure research and development defense agency funding legislation, appropriations and oversight.
Small molecule medical countermeasure research and development agency funding, legislation, appropriations, and oversight.
Filing targets: Army, Dept of (Other), Ballistic Missile Defense Organization, Centers For Disease Control & Prevention (CDC), Defense Threat Reduction Agency (DTRA), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Natl Institutes of Health (NIH), SENATE, White House Office
BRIGHTON BIOTECH, INC. via DALRYMPLE & ASSOCIATES, LLC
2011 · first_quarter · RR
Government agency Therapeutic product R&D funding opportunities
Government agency Therapeutic product R&D funding opportunities
Government agency Therapeutic product R&D funding opportunities
EMERGENT BIOSOLUTIONS INC (FORMERLY BIOPORT CORPORATION) via DALRYMPLE & ASSOCIATES, LLC
2011 · first_quarter · Q1
Anthrax vaccine and immunoglobulin research, acquisition, immunization, legislation, funding, appropriations and oversight.
Anthrax vaccine and anthrax immune globulin research, acquisition and immunization funding, legislation, appropriations, and oversight.
Biodefense and naturally-occurring vaccine and related biological therapeutic products and civilian oncology therapeutic products research and development funding, legislation, appropriations and oversight.
Filing targets: Army, Dept of (Other), Ballistic Missile Defense Organization, Centers For Disease Control & Prevention (CDC), Defense Threat Reduction Agency (DTRA), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Natl Institutes of Health (NIH), SENATE, White House Office
SANOFI PASTEUR via DALRYMPLE & ASSOCIATES, LLC
2011 · first_quarter · Q1
Vaccine and immunization finance, reimbursement, acquisition, regulation, standards of quality and care, liability, public health and emergency preparedness funding, legislation, appropriations and oversight.
Vaccine research and development legislation, funding, appropriations and oversight.
Filing targets: Army, Dept of (Other), Centers For Disease Control & Prevention (CDC), Defense Threat Reduction Agency (DTRA), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE, State, Dept of (DOS), U.S. Agency for International Development (USAID), Veterans Affairs, Dept of (VA), White House Office
PULMATRIX, INC. via DALRYMPLE & ASSOCIATES, LLC
2010 · fourth_quarter · Q4
Appropriations and funding under federal government contracts for development of broad spectrum products and delivery systems for the prevention, prophylaxis, treatment and halting transmission of infectious respiratory diseases.
Filing targets: Army, Dept of (Other), Centers For Disease Control & Prevention (CDC), Defense Advanced Research Projects Agency (DARPA), Defense Threat Reduction Agency (DTRA), Defense, Dept of (DOD), Executive Office of the President (EOP), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Natl Institutes of Health (NIH), SENATE, State, Dept of (DOS)
SANOFI PASTEUR via DALRYMPLE & ASSOCIATES, LLC
2010 · fourth_quarter · Q4
Vaccine and immunization finance, reimbursement, acquisition, regulation, standards of quality and care, liability, public health and emergency preparedness funding, legislation, appropriations and oversight.
Vaccine research and development legislation, funding, appropriations and oversight.
Filing targets: Army, Dept of (Other), Centers For Disease Control & Prevention (CDC), Defense Threat Reduction Agency (DTRA), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE, State, Dept of (DOS), U.S. Agency for International Development (USAID), Veterans Affairs, Dept of (VA), White House Office
EMERGENT BIOSOLUTIONS INC (FORMERLY BIOPORT CORPORATION) via DALRYMPLE & ASSOCIATES, LLC
2010 · fourth_quarter · Q4
Anthrax vaccine and anthrax immune globulin research, acquisition and immunization funding, legislation, appropriations, and oversight.
Biodefense and naturally-occurring vaccine and related biological products research and development funding, legislation, appropriations and oversight.
Anthrax vaccine and immunoglobulin research, acquisition, immunization, legislation, funding, appropriations and oversight.
Filing targets: Army, Dept of (Other), Ballistic Missile Defense Organization, Centers For Disease Control & Prevention (CDC), Defense Threat Reduction Agency (DTRA), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Natl Institutes of Health (NIH), SENATE, White House Office
PULMATRIX, INC. via DALRYMPLE & ASSOCIATES, LLC
2010 · third_quarter · Q3
Appropriations and funding under federal government contracts for development of broad spectrum products and delivery systems for the prevention, prophylaxis, treatment and halting transmission of infectious respiratory diseases.
Filing targets: Army, Dept of (Other), Centers For Disease Control & Prevention (CDC), Defense Advanced Research Projects Agency (DARPA), Defense Threat Reduction Agency (DTRA), Defense, Dept of (DOD), Executive Office of the President (EOP), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Natl Institutes of Health (NIH), SENATE, State, Dept of (DOS)
SANOFI PASTEUR via DALRYMPLE & ASSOCIATES, LLC
2010 · third_quarter · Q3
Vaccine research and development legislation, funding, appropriations and oversight.
Vaccine and immunization finance, reimbursement, acquisition, regulation, standards of quality and care, liability, public health and emergency preparedness funding, legislation, appropriations and oversight.
Filing targets: Army, Dept of (Other), Centers For Disease Control & Prevention (CDC), Defense Threat Reduction Agency (DTRA), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE, State, Dept of (DOS), U.S. Agency for International Development (USAID), Veterans Affairs, Dept of (VA), White House Office
EMERGENT BIOSOLUTIONS INC (FORMERLY BIOPORT CORPORATION) via DALRYMPLE & ASSOCIATES, LLC
2010 · third_quarter · Q3
Anthrax vaccine and anthrax immune globulin research, acquisition and immunization funding, legislation, appropriations, and oversight.
Biodefense and naturally-occurring vaccine and related biological products research and development funding, legislation, appropriations and oversight.
Anthrax vaccine and immunoglobulin research, acquisition, immunization, legislation, funding, appropriations and oversight.
Filing targets: Army, Dept of (Other), Ballistic Missile Defense Organization, Centers For Disease Control & Prevention (CDC), Defense Threat Reduction Agency (DTRA), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Natl Institutes of Health (NIH), SENATE, White House Office
PULMATRIX, INC. via DALRYMPLE & ASSOCIATES, LLC
2010 · second_quarter · Q2
Appropriations and funding under federal government contracts for development of broad spectrum products and delivery systems for the prevention, prophylaxis, treatment and halting transmission of infectious respiratory diseases.
Filing targets: Army, Dept of (Other), Centers For Disease Control & Prevention (CDC), Defense Advanced Research Projects Agency (DARPA), Defense Threat Reduction Agency (DTRA), Defense, Dept of (DOD), Executive Office of the President (EOP), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Natl Institutes of Health (NIH), SENATE, State, Dept of (DOS)
EMERGENT BIOSOLUTIONS INC (FORMERLY BIOPORT CORPORATION) via DALRYMPLE & ASSOCIATES, LLC
2010 · second_quarter · Q2
Anthrax vaccine and immunoglobulin research, acquisition, immunization, legislation, funding, appropriations and oversight.
Anthrax vaccine and anthrax immune globulin research, acquisition and immunization funding, legislation, appropriations, and oversight.
Biodefense and naturally-occurring vaccine and related biological products research and development funding, legislation, appropriations and oversight.
Filing targets: Army, Dept of (Other), Ballistic Missile Defense Organization, Centers For Disease Control & Prevention (CDC), Defense Threat Reduction Agency (DTRA), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Natl Institutes of Health (NIH), SENATE, White House Office
SANOFI PASTEUR via DALRYMPLE & ASSOCIATES, LLC
2010 · second_quarter · Q2
Vaccine research and development legislation, funding, appropriations and oversight.
Vaccine and immunization finance, reimbursement, acquisition, regulation, standards of quality and care, liability, public health and emergency preparedness funding, legislation, appropriations and oversight.
Filing targets: Army, Dept of (Other), Centers For Disease Control & Prevention (CDC), Defense Threat Reduction Agency (DTRA), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE, State, Dept of (DOS), U.S. Agency for International Development (USAID), Veterans Affairs, Dept of (VA), White House Office
PULMATRIX, INC. via DALRYMPLE & ASSOCIATES, LLC
2010 · first_quarter · Q1
Appropriations and funding under federal government contracts for development of broad spectrum products and delivery systems for the prevention, prophylaxis, treatment and halting transmission of infectious respiratory diseases.
Filing targets: Army, Dept of (Other), Centers For Disease Control & Prevention (CDC), Defense Advanced Research Projects Agency (DARPA), Defense Threat Reduction Agency (DTRA), Defense, Dept of (DOD), Executive Office of the President (EOP), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Natl Institutes of Health (NIH), SENATE, State, Dept of (DOS)
SANOFI PASTEUR via DALRYMPLE & ASSOCIATES, LLC
2010 · first_quarter · Q1
Vaccine research and development legislation, funding, appropriations and oversight.
Vaccine and immunization finance, reimbursement, acquisition, regulation, standards of quality and care, liability, public health and emergency preparedness funding, legislation, appropriations and oversight.
Filing targets: Army, Dept of (Other), Centers For Disease Control & Prevention (CDC), Defense Threat Reduction Agency (DTRA), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE, State, Dept of (DOS), U.S. Agency for International Development (USAID), Veterans Affairs, Dept of (VA), White House Office
EMERGENT BIOSOLUTIONS INC (FORMERLY BIOPORT CORPORATION) via DALRYMPLE & ASSOCIATES, LLC
2010 · first_quarter · Q1
Anthrax vaccine and anthrax immune globulin research, acquisition and immunization funding, legislation, appropriations, and oversight.
Biodefense and naturally-occurring vaccine and related biological products research and development funding, legislation, appropriations and oversight.
Anthrax vaccine and immunoglobulin research, acquisition, immunization, legislation, funding, appropriations and oversight.
Filing targets: Army, Dept of (Other), Ballistic Missile Defense Organization, Centers For Disease Control & Prevention (CDC), Defense Threat Reduction Agency (DTRA), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Natl Institutes of Health (NIH), SENATE, White House Office
PULMATRIX, INC. via DALRYMPLE & ASSOCIATES, LLC
2009 · fourth_quarter · Q4
Appropriations and funding under federal government contracts for development of broad spectrum products and delivery systems for the prevention, prophylaxis, treatment and halting transmission of infectious respiratory diseases.
Filing targets: Army, Dept of (Other), Centers For Disease Control & Prevention (CDC), Defense Advanced Research Projects Agency (DARPA), Defense Threat Reduction Agency (DTRA), Defense, Dept of (DOD), Executive Office of the President (EOP), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Natl Institutes of Health (NIH), SENATE, State, Dept of (DOS)
EMERGENT BIOSOLUTIONS INC (FORMERLY BIOPORT CORPORATION) via DALRYMPLE & ASSOCIATES, LLC
2009 · fourth_quarter · Q4
Anthrax vaccine and anthrax immune globulin research, acquisition and immunization funding, legislation, appropriations, and oversight.
Anthrax vaccine and immunoglobulin research, acquisition, immunization, legislation, funding, appropriations and oversight.
Biodefense and naturally-occurring vaccine and related biological products research and development funding, legislation, appropriations and oversight.
Filing targets: Army, Dept of (Other), Ballistic Missile Defense Organization, Centers For Disease Control & Prevention (CDC), Defense Threat Reduction Agency (DTRA), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Natl Institutes of Health (NIH), SENATE, White House Office
SANOFI PASTEUR via DALRYMPLE & ASSOCIATES, LLC
2009 · fourth_quarter · Q4
Vaccine research and development legislation, funding, appropriations and oversight.
Vaccine and immunization finance, reimbursement, acquisition, regulation, standards of quality and care, liability, public health and emergency preparedness funding, legislation, appropriations and oversight.
Filing targets: Army, Dept of (Other), Centers For Disease Control & Prevention (CDC), Defense Threat Reduction Agency (DTRA), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE, State, Dept of (DOS), U.S. Agency for International Development (USAID), Veterans Affairs, Dept of (VA), White House Office
PULMATRIX, INC. via DALRYMPLE & ASSOCIATES, LLC
2009 · third_quarter · Q3
Appropriations and funding under federal government contracts for development of broad spectrum products and delivery systems for the prevention, prophylaxis, treatment and halting transmission of infectious respiratory diseases.
Filing targets: Army, Dept of (Other), Centers For Disease Control & Prevention (CDC), Defense Advanced Research Projects Agency (DARPA), Defense Threat Reduction Agency (DTRA), Defense, Dept of (DOD), Executive Office of the President (EOP), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Natl Institutes of Health (NIH), SENATE, State, Dept of (DOS)
SANOFI PASTEUR via DALRYMPLE & ASSOCIATES, LLC
2009 · third_quarter · Q3
Vaccine research and development legislation, funding, appropriations and oversight.
Vaccine and immunization finance, reimbursement, acquisition, regulation, standards of quality and care, liability, public health and emergency preparedness funding, legislation, appropriations and oversight.
Filing targets: Army, Dept of (Other), Centers For Disease Control & Prevention (CDC), Defense Threat Reduction Agency (DTRA), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE, State, Dept of (DOS), U.S. Agency for International Development (USAID), Veterans Affairs, Dept of (VA), White House Office
EMERGENT BIOSOLUTIONS INC (FORMERLY BIOPORT CORPORATION) via DALRYMPLE & ASSOCIATES, LLC
2009 · third_quarter · Q3
Anthrax vaccine and anthrax immune globulin research, acquisition and immunization funding, legislation, appropriations, and oversight.
Biodefense and naturally-occurring vaccine and related biological products research and development funding, legislation, appropriations and oversight.
Anthrax vaccine and immunoglobulin research, acquisition, immunization, legislation, funding, appropriations and oversight.
Filing targets: Army, Dept of (Other), Ballistic Missile Defense Organization, Centers For Disease Control & Prevention (CDC), Defense Threat Reduction Agency (DTRA), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Natl Institutes of Health (NIH), SENATE, White House Office
CRUCELL, NA via DALRYMPLE & ASSOCIATES, LLC
2009 · third_quarter · 3T
Government appropriations and contracts in support of development of vaccines and therapeutic medical countermeasures against both naturally-occurring infectious diseases such as seasonal and pandemic influenza and staph aureus and potential bioterrorist threats from Ebola and Marburg filoviruses
Filing targets: Centers For Disease Control & Prevention (CDC), Defense Threat Reduction Agency (DTRA), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Natl Institutes of Health (NIH), SENATE
PULMATRIX, INC. via DALRYMPLE & ASSOCIATES, LLC
2009 · second_quarter · Q2
Appropriations and funding under federal government contracts for development of broad spectrum products and delivery systems for the prevention, prophylaxis, treatment and halting transmission of infectious respiratory diseases.
Filing targets: Army, Dept of (Other), Centers For Disease Control & Prevention (CDC), Defense Advanced Research Projects Agency (DARPA), Defense Threat Reduction Agency (DTRA), Defense, Dept of (DOD), Executive Office of the President (EOP), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Natl Institutes of Health (NIH), SENATE, State, Dept of (DOS)
CRUCELL, NA via DALRYMPLE & ASSOCIATES, LLC
2009 · second_quarter · Q2
Government appropriations and contracts in support of development of vaccines and therapeutic medical countermeasures against both naturally-occurring infectious diseases such as seasonal and pandemic influenza and staph aureus and potential bioterrorist threats from Ebola and Marburg filoviruses
Filing targets: Centers For Disease Control & Prevention (CDC), Defense Threat Reduction Agency (DTRA), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Natl Institutes of Health (NIH), SENATE
EMERGENT BIOSOLUTIONS INC (FORMERLY BIOPORT CORPORATION) via DALRYMPLE & ASSOCIATES, LLC
2009 · second_quarter · Q2
Anthrax vaccine and immunoglobulin research, acquisition, immunization, legislation, funding, appropriations and oversight.
Biodefense and naturally-occurring vaccine and related biological products research and development funding, legislation, appropriations and oversight.
Anthrax vaccine and anthrax immune globulin research, acquisition and immunization funding, legislation, appropriations, and oversight.
Filing targets: Army, Dept of (Other), Ballistic Missile Defense Organization, Centers For Disease Control & Prevention (CDC), Defense Threat Reduction Agency (DTRA), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Natl Institutes of Health (NIH), SENATE, White House Office
SANOFI PASTEUR via DALRYMPLE & ASSOCIATES, LLC
2009 · second_quarter · Q2
Vaccine and immunization finance, reimbursement, acquisition, regulation, standards of quality and care, liability, public health and emergency preparedness funding, legislation, appropriations and oversight.
Vaccine research and development legislation, funding, appropriations and oversight.
Filing targets: Army, Dept of (Other), Centers For Disease Control & Prevention (CDC), Defense Threat Reduction Agency (DTRA), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE, State, Dept of (DOS), U.S. Agency for International Development (USAID), Veterans Affairs, Dept of (VA), White House Office
PULMATRIX, INC. via DALRYMPLE & ASSOCIATES, LLC
2009 · first_quarter · Q1
Appropriations and funding under federal government contracts for development of broad spectrum products and delivery systems for the prevention, prophylaxis, treatment and halting transmission of infectious respiratory diseases.
Filing targets: Army, Dept of (Other), Centers For Disease Control & Prevention (CDC), Defense Advanced Research Projects Agency (DARPA), Defense Threat Reduction Agency (DTRA), Defense, Dept of (DOD), Executive Office of the President (EOP), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Natl Institutes of Health (NIH), SENATE, State, Dept of (DOS)
PULMATRIX, INC. via DALRYMPLE & ASSOCIATES, LLC
2009 · first_quarter · RA
Appropriations and government contracts for development of new therapeutics for prevention, prophylaxis, treatment and transmission of respiratory infectious diseases
CRUCELL, NA via DALRYMPLE & ASSOCIATES, LLC
2009 · first_quarter · Q1
Government appropriations and contracts in support of development of vaccines and therapeutic medical countermeasures against both naturally-occurring infectious diseases such as seasonal and pandemic influenza and staph aureus and potential bioterrorist threats from Ebola and Marburg filoviruses
Filing targets: Centers For Disease Control & Prevention (CDC), Defense Threat Reduction Agency (DTRA), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Natl Institutes of Health (NIH), SENATE
SANOFI PASTEUR via DALRYMPLE & ASSOCIATES, LLC
2009 · first_quarter · Q1
Vaccine research and development legislation, funding, appropriations and oversight.
Vaccine and immunization finance, reimbursement, acquisition, regulation, standards of quality and care, liability, public health and emergency preparedness funding, legislation, appropriations and oversight.
Filing targets: Army, Dept of (Other), Centers For Disease Control & Prevention (CDC), Defense Threat Reduction Agency (DTRA), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE, State, Dept of (DOS), U.S. Agency for International Development (USAID), Veterans Affairs, Dept of (VA), White House Office
EMERGENT BIOSOLUTIONS INC (FORMERLY BIOPORT CORPORATION) via DALRYMPLE & ASSOCIATES, LLC
2009 · first_quarter · Q1
Anthrax vaccine and immunoglobulin research, acquisition, immunization, legislation, funding, appropriations and oversight.
Biodefense and naturally-occurring vaccine and related biological products research and development funding, legislation, appropriations and oversight.
Anthrax vaccine and anthrax immune globulin research, acquisition and immunization funding, legislation, appropriations, and oversight.
Filing targets: Army, Dept of (Other), Ballistic Missile Defense Organization, Centers For Disease Control & Prevention (CDC), Defense Threat Reduction Agency (DTRA), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Natl Institutes of Health (NIH), SENATE, White House Office
CRUCELL, NA via DALRYMPLE & ASSOCIATES, LLC
2009 · first_quarter · RR
Infectious Disease and Biodefense Vaccine & Therapeutic Product R&D and acquisition funded by HHS, NIAID, CDC, DOD, DTRA, JPOCBD and related authorization and appropriations legislation
Infectious Disease and Biodefense Vaccine & Therapeutic Product R&D and acquisition funded by HHS, NIAID, CDC, DOD, DTRA, JPOCBD and related authorization and appropriations legislation
Infectious Disease and Biodefense Vaccine & Therapeutic Product R&D and acquisition funded by HHS, NIAID, CDC, DOD, DTRA, JPOCBD and related authorization and appropriations legislation
PULMATRIX, INC. via DALRYMPLE & ASSOCIATES, LLC
2008 · fourth_quarter · RR
Pandemic Influenza, Infectious Disease and Biodefense Therapeutics Products R&D and acquisition funded by HHS, NIAID, CDC, DOD, DTRA, JPOCBD and related authorization and appropriations legislation
Pandemic Influenza, Infectious Disease and Biodefense Therapeutics Products R&D and acquisition funded by HHS, NIAID, CDC, DOD, DTRA, JPOCBD and related authorization and appropriations legislation
Pandemic Influenza, Infectious Disease and Biodefense Therapeutics Products R&D and acquisition funded by HHS, NIAID, CDC, DOD, DTRA, JPOCBD and related authorization and appropriations legislation
SANOFI PASTEUR via DALRYMPLE & ASSOCIATES, LLC
2008 · fourth_quarter · Q4
Vaccine and immunization finance, reimbursement, acquisition, regulation, standards of quality and care, liability, public health and emergency preparedness funding, legislation, appropriations and oversight.
Vaccine research and development legislation, funding, appropriations and oversight.
Filing targets: Army, Dept of (Other), Centers For Disease Control & Prevention (CDC), Defense Threat Reduction Agency (DTRA), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE, State, Dept of (DOS), U.S. Agency for International Development (USAID), Veterans Affairs, Dept of (VA), White House Office
EMERGENT BIOSOLUTIONS INC (FORMERLY BIOPORT CORPORATION) via DALRYMPLE & ASSOCIATES, LLC
2008 · fourth_quarter · Q4
Anthrax vaccine and anthrax immune globulin research, acquisition and immunization funding, legislation, appropriations, and oversight.
Biodefense and naturally-occurring vaccine and related biological products research and development funding, legislation, appropriations and oversight.
Anthrax vaccine and immunoglobulin research, acquisition, immunization, legislation, funding, appropriations and oversight.
Filing targets: Army, Dept of (Other), Ballistic Missile Defense Organization, Centers For Disease Control & Prevention (CDC), Defense Threat Reduction Agency (DTRA), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Natl Institutes of Health (NIH), SENATE, White House Office
Filing targets: Centers For Disease Control & Prevention (CDC), Defense Advanced Research Projects Agency (DARPA), Defense Logistics Agency, Defense Threat Reduction Agency (DTRA), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Joint Chiefs of Staff, Natl Institutes of Health (NIH), SENATE, White House Office
Filing targets: Centers For Disease Control & Prevention (CDC), Defense Advanced Research Projects Agency (DARPA), Defense Logistics Agency, Defense Threat Reduction Agency (DTRA), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Joint Chiefs of Staff, Natl Institutes of Health (NIH), SENATE, White House Office
Filing targets: Army, Dept of (Other), Ballistic Missile Defense Organization, Centers For Disease Control & Prevention (CDC), Defense Threat Reduction Agency (DTRA), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Natl Institutes of Health (NIH), SENATE, White House Office
Filing targets: Army, Dept of (Other), Ballistic Missile Defense Organization, Centers For Disease Control & Prevention (CDC), Defense Threat Reduction Agency (DTRA), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Natl Institutes of Health (NIH), SENATE, White House Office
Filing targets: Army, Dept of (Other), Ballistic Missile Defense Organization, Centers For Disease Control & Prevention (CDC), Defense Threat Reduction Agency (DTRA), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Natl Institutes of Health (NIH), SENATE, White House Office
Filing targets: Army, Dept of (Other), Ballistic Missile Defense Organization, Centers For Disease Control & Prevention (CDC), Defense Threat Reduction Agency (DTRA), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Natl Institutes of Health (NIH), SENATE, White House Office
Acquisition and R&D support for anthrax vaccine and other CBRN medical countermeasures
Filing targets: Centers For Disease Control & Prevention (CDC), Defense Advanced Research Projects Agency (DARPA), Defense Threat Reduction Agency (DTRA), Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Homeland Security, Dept of (DHS), Natl Institutes of Health (NIH), SENATE
Filing targets: Army, Dept of (Other), Ballistic Missile Defense Organization, Centers For Disease Control & Prevention (CDC), Defense Threat Reduction Agency (DTRA), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Natl Institutes of Health (NIH), SENATE, White House Office
Filing targets: Army, Dept of (Other), Ballistic Missile Defense Organization, Centers For Disease Control & Prevention (CDC), Defense Threat Reduction Agency (DTRA), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Natl Institutes of Health (NIH), SENATE, White House Office
Filing targets: Army, Dept of (Other), Ballistic Missile Defense Organization, Centers For Disease Control & Prevention (CDC), Defense Threat Reduction Agency (DTRA), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Natl Institutes of Health (NIH), SENATE, White House Office
Filing targets: Army, Dept of (Other), Ballistic Missile Defense Organization, Centers For Disease Control & Prevention (CDC), Defense Threat Reduction Agency (DTRA), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Natl Institutes of Health (NIH), SENATE, White House Office
Filing targets: Army, Dept of (Other), Ballistic Missile Defense Organization, Centers For Disease Control & Prevention (CDC), Defense Threat Reduction Agency (DTRA), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Natl Institutes of Health (NIH), SENATE, White House Office
Filing targets: Army, Dept of (Other), Ballistic Missile Defense Organization, Centers For Disease Control & Prevention (CDC), Defense Threat Reduction Agency (DTRA), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Natl Institutes of Health (NIH), SENATE, White House Office
Filing targets: Army, Dept of (Other), Ballistic Missile Defense Organization, Centers For Disease Control & Prevention (CDC), Defense Threat Reduction Agency (DTRA), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Natl Institutes of Health (NIH), SENATE, White House Office
Filing targets: Army, Dept of (Other), Ballistic Missile Defense Organization, Centers For Disease Control & Prevention (CDC), Defense Threat Reduction Agency (DTRA), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Natl Institutes of Health (NIH), SENATE, White House Office